The impact of changes in HIV management guidelines on time to treatment initiation in Australia.

Puhr, R; Petoumenos, K; Youds, D; Law, M G; Templeton, D J

Puhr, R; Petoumenos, K; Youds, D; Law, M G; Templeton, D J.

Affiliation

Puhr R; The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
Petoumenos K; The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
Youds D; Gladstone Road Medical Centre, Highgate Hill, QLD, Australia.
Law MG; The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
Templeton DJ; The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.

HIV Med ; 18(9): 701-703, 2017 10.

Article in En | MEDLINE | ID: mdl-28224755

Subject(s)

Anti-HIV Agents/therapeutic use; HIV Infections/drug therapy; Time-to-Treatment/trends; Adolescent; Adult; Aged; Aged, 80 and over; Antiretroviral Therapy, Highly Active; Australia/epidemiology; CD4 Lymphocyte Count; Female; HIV Infections/immunology; HIV Infections/mortality; Humans; Male; Middle Aged; Practice Guidelines as Topic; Young Adult

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents / Time-to-Treatment Type of study: Guideline Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Oceania Language: En Journal: HIV Med Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2017 Document type: Article Affiliation country: Australia Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google